Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

Background— The relation between endogenous testosterone concentrations and health in men is controversial. Methods and Results— We examined the prospective relationship between endogenous testosterone concentrations and mortality due to all causes, cardiovascular disease, and cancer in a nested case-control study based on 11 606 men aged 40 to 79 years surveyed in 1993 to 1997 and followed up to 2003. Among those without prevalent cancer or cardiovascular disease, 825 men who subsequently died were compared with a control group of 1489 men still alive, matched for age and date of baseline visit. Endogenous testosterone concentrations at baseline were inversely related to mortality due to all causes (825 deaths), cardiovascular disease (369 deaths), and cancer (304 deaths). Odds ratios (95% confidence intervals) for mortality for increasing quartiles of endogenous testosterone compared with the lowest quartile were 0.75 (0.55 to 1.00), 0.62 (0.45 to 0.84), and 0.59 (0.42 to 0.85), respectively (P<0.001 for trend after adjustment for age, date of visit, body mass index, systolic blood pressure, blood cholesterol, cigarette smoking, diabetes mellitus, alcohol intake, physical activity, social class, education, dehydroepiandrosterone sulfate, androstanediol glucuronide, and sex hormone binding globulin). An increase of 6 nmol/L serum testosterone (≈1 SD) was associated with a 0.81 (95% confidence interval 0.71 to 0.92, P<0.01) multivariable-adjusted odds ratio for mortality. Inverse relationships were also observed for deaths due to cardiovascular causes and cancer and after the exclusion of deaths that occurred in the first 2 years. Conclusions— In men, endogenous testosterone concentrations are inversely related to mortality due to cardiovascular disease and all causes. Low testosterone may be a predictive marker for those at high risk of cardiovascular disease.

[1]  W. Bremner,et al.  Advances in male contraception. , 2008, Endocrine reviews.

[2]  S. Horie,et al.  DHEA and testosterone in the elderly. , 2007, The New England journal of medicine.

[3]  T. Perls DHEA and testosterone in the elderly. , 2007, New England Journal of Medicine.

[4]  Claudio Cobelli,et al.  DHEA in elderly women and DHEA or testosterone in elderly men. , 2006, The New England journal of medicine.

[5]  N. Day,et al.  Work and leisure time physical activity assessed using a simple, pragmatic, validated questionnaire and incident cardiovascular disease and all-cause mortality in men and women: The European Prospective Investigation into Cancer in Norfolk prospective population study. , 2006, International journal of epidemiology.

[6]  J. Murabito,et al.  Endogenous Sex Hormones and Cardiovascular Disease Incidence in Men , 2006, Annals of Internal Medicine.

[7]  E. Ding,et al.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.

[8]  J. Kaufman,et al.  The decline of androgen levels in elderly men and its clinical and therapeutic implications. , 2005, Endocrine reviews.

[9]  D. Grobbee,et al.  Endogenous Sex Hormones and Progression of Carotid Atherosclerosis in Elderly Men , 2004, Circulation.

[10]  H. Javitz,et al.  Relationship of endogenous sex hormones to coronary heart disease: a twin study. , 2004, The Journal of clinical endocrinology and metabolism.

[11]  G. B. Phillips,et al.  Are major risk factors for myocardial infarction the major predictors of degree of coronary artery disease in men? , 2004, Metabolism: clinical and experimental.

[12]  E. Barrett-Connor,et al.  Time for (more research on) testosterone. , 2004, The Journal of clinical endocrinology and metabolism.

[13]  A. Morgentaler,et al.  Risks of testosterone-replacement therapy and recommendations for monitoring. , 2004, The New England journal of medicine.

[14]  D. Blazer,et al.  Testosterone and Aging , 2004 .

[15]  L. Niskanen,et al.  Sex hormones, inflammation and the metabolic syndrome: a population-based study. , 2003, European journal of endocrinology.

[16]  D. Grobbee,et al.  Grobbee Endogenous Sex Hormones and Cardiovascular Disease in Men Society , 2003 .

[17]  Jo Mitchell,et al.  Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study , 2003, Public Health Nutrition.

[18]  David Handelsman,et al.  Androgens and cardiovascular disease. , 2003, Endocrine reviews.

[19]  A. von Eckardstein,et al.  Androgens and coronary artery disease. , 2003, Endocrine reviews.

[20]  K. Channer,et al.  The vasodilatory action of testosterone: a potassium‐channel opening or a calcium antagonistic action? , 2003, British journal of pharmacology.

[21]  A. Matsumoto,et al.  Testosterone Supplementation Therapy for Older Men: Potential Benefits and Risks , 2003, Journal of the American Geriatrics Society.

[22]  M. Bots,et al.  Endogenous hormones and carotid atherosclerosis in elderly men. , 2003, American journal of epidemiology.

[23]  A. Hofman,et al.  Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. , 2002, The Journal of clinical endocrinology and metabolism.

[24]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[25]  C. Huggins,et al.  Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. , 2002, The Journal of urology.

[26]  N. Skakkebaek,et al.  Cardiovascular risk factors in men: The role of gonadal steroids and sex hormone-binding globulin. , 2001, Metabolism: clinical and experimental.

[27]  R. Steeds,et al.  Chronic Stable Angina : A Randomized , Double-Blind , Placebo-Controlled Study Low-Dose Transdermal Testosterone Therapy Improves Angina Threshold in Men With , 2000 .

[28]  C. Hayward,et al.  Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. , 1999, Circulation.

[29]  N. Day,et al.  EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. , 1999, British journal of cancer.

[30]  T. Key,et al.  Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies , 1999, British Journal of Cancer.

[31]  C. Webb,et al.  Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. , 1999, The American journal of cardiology.

[32]  E. Vittinghoff,et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.

[33]  M. Charles,et al.  Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study. , 1997, The Journal of clinical endocrinology and metabolism.

[34]  L. Kuller,et al.  Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. , 1996, American journal of epidemiology.

[35]  W. Bremner,et al.  Androgens in men--uses and abuses. , 1996, The New England journal of medicine.

[36]  S. Haffner Sex hormone-binding protein, hyperinsulinemia, insulin resistance and noninsulin-dependent diabetes. , 1996, Hormone research.

[37]  G. B. Phillips,et al.  The association of hypotestosteronemia with coronary artery disease in men. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[38]  M. Barbagallo,et al.  Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension , 1993, Journal of hypertension.

[39]  J. Yarnell,et al.  Endogenous sex hormones and ischemic heart disease in men. The Caerphilly prospective study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[40]  A. Vermeulen,et al.  Representativeness of a single point plasma testosterone level for the long term hormonal milieu in men. , 1992, The Journal of clinical endocrinology and metabolism.

[41]  E. Barrett-Connor,et al.  Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[42]  J. Fleg,et al.  Plasma levels of estradiol, testosterone, and DHEAS do not predict risk of coronary artery disease in men. , 1990, Journal of andrology.

[43]  E. Barrett-Connor,et al.  Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. , 1988, Circulation.

[44]  S. Haffner,et al.  The relationship of sex hormones to hyperinsulinemia and hyperglycemia. , 1988, Metabolism: clinical and experimental.

[45]  E. Barrett-Connor,et al.  Blood pressure and endogenous testosterone in men: an inverse relationship. , 1988, Journal of hypertension.

[46]  K. Yano,et al.  Serum sex hormone levels and myocardial infarction in the Honolulu Heart Program. Pitfalls in prospective studies on sex hormones. , 1988, Journal of clinical epidemiology.

[47]  P. Elwood,et al.  Sex hormones, insulin, lipids, and prevalent ischemic heart disease. , 1987, American journal of epidemiology.

[48]  L. Kuller,et al.  Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. , 1987, The American journal of cardiology.

[49]  I. Murray-Lyon,et al.  LIVER DAMAGE FROM LONG-TERM METHYLTESTOSTERONE , 1977, The Lancet.

[50]  G B Phillips,et al.  Relationship between serum sex hormones and glucose, insulin and lipid abnormalities in men with myocardial infarction. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[51]  C. Huggins,et al.  Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate , 1941, CA: a cancer journal for clinicians.